AptarGroup, Inc. AptarGroup, Inc.

AptarGroup, Inc.

ATR

株式のランク #2445
AptarGroup, Inc. specializes in developing and manufacturing solutions for... AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
株価
$125.90
最終同期: 2026-10-20
時価総額
$8.00B
変化(1日)
0.93%
変化(1年)
-3.58%
国
US
取引 AptarGroup, Inc. (ATR)

カテゴリー

Healthcare
AptarGroup, Inc.(ATR)のP/E比率
October 2026 時点のP/E比率 TTM 21.48
AptarGroup, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 21.48 です。2024 年末時点での P/E は 27.82 でした。
AptarGroup, Inc. の P/E 比率の履歴(2000 〜 2026)
各年末のP/E比率
年 P/E比率 変化
2026 (TTM) 21.48 5.23%
2025 20.41 -26.64%
2024 27.82 -2.42%
2023 28.51 -5.15%
2022 30.06 -8.77%
2021 32.95 -20.03%
2020 41.20 35.75%
2019 30.35 0.63%
2018 30.16 23.19%
2017 24.48 9.11%
2016 22.44 -1.63%
2015 22.81 0.60%
2014 22.67 -12.99%
2013 26.06 33.74%
2012 19.48 3.07%
2011 18.90 2.36%
2010 18.47 -4.81%
2009 19.40 24.53%
2008 15.58 -21.52%
2007 19.85 -0.82%
2006 20.01 8.89%
2005 18.38 -10.15%
2004 20.46 15.92%
2003 17.65 5.07%
2002 16.80 -21.39%
2001 21.37 30.90%
2000 16.32 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差 国
47.48 121.10%
US
27.43 27.70%
FR
- -
JP
56.89 164.91%
US
- -
CH
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。